- Ionis Pharmaceuticals, Inc.
Ionis is unlocking the rapidly expanding potential of RNA- and DNA-targeted medicines to enable better futures for people living with serious diseases
- Investors Media | Ionis Pharmaceuticals, Inc.
Ionis currently has six marketed medicines and a leading pipeline in neurology, cardiology and select areas of high patient need As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing
- Ionis Pharmaceuticals - Wikipedia
Ionis Pharmaceuticals, Inc is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics
- Ionis Pharmaceuticals, Inc. (IONS) Stock Price, News, Quote . . .
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs Its broad clinical and preclinical pipeline targets a wide variety of
- Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs Its broad clinical and preclinical pipeline targets a wide variety of
- GAMMA Investing LLC Acquires 28,247 Shares of Ionis . . .
Ionis Pharmaceuticals Stock Performance IONS stock traded up $0 90 during midday trading on Wednesday, reaching $37 05 202,850 shares of the company's stock traded hands, compared to its average volume of 1,588,020 Ionis Pharmaceuticals, Inc has a 52-week low of $23 95 and a 52-week high of $52 34
- Ionis Pharmaceuticals (IONS) Stock Price Overview
Get a real-time Ionis Pharmaceuticals, Inc (IONS) stock price with an overview of financials, statistics, forecasts, charts and more
|